<p class="jove_content">This protocol combines pan-cancer bioinformatics analysis with immunohistochemical validation in colon cancer to evaluate Transmembrane Emp24 Protein Transport Domain 3 expression, prognostic significance, immune associations, and related biological pathways using public multiomics databases and clinical tissue samples.</p>

pan-cancer-bioinformatics-analysis-combined-with-colon-cancer

Pan-cancer Bioinformatics Analysis Combined with Colon Cancer Experimental Validation: A Study on TMED3 as a Diagnostic and Prognostic Biomarker

Transmembrane Emp24 Protein Transport Domain 3 (TMED3), a member of the p24 protein family, has been implicated in tumor proliferation, invasion, and ...

Institution - Tangshan Central Hospital

Articles Published in JoVE